BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6776782)

  • 1. Influence of diphenylhydantoin on lysosomal enzyme release during bone resorption in vitro.
    Lerner U; Hänström L
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):144-50. PubMed ID: 6776782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin stimulates bone resorption and lysosomal-enzyme release in cultured mouse calvaria.
    Gustafson GT; Lerner U
    Biochem J; 1984 Apr; 219(1):329-32. PubMed ID: 6721862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of bone resorption in vitro by serine-esterase inhibitors.
    Lerner UH; Gustafson GT
    Biochim Biophys Acta; 1988 Feb; 964(2):129-36. PubMed ID: 3342254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of dibutyryl cyclic AMP on the release of calcium, inorganic phosphate and lysosomal enzymes from calvarial bones cultured for 24 hours.
    Lerner U; Gustafson GT
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):730-42. PubMed ID: 227206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro.
    Lerner UH; Larsson A
    Bone; 1987; 8(3):179-89. PubMed ID: 2955802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro.
    Lerner UH; Ransjö M; Ljunggren O
    Calcif Tissue Int; 1987 Jun; 40(6):323-31. PubMed ID: 2440532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levamisole inhibits mineral mobilisation, lactate production and lysosomal enzyme release from cultured bones.
    Lerner U; Gustafson GT
    Experientia; 1979 Apr; 35(4):525-6. PubMed ID: 437047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphenylhydantoin inhibits parathyroid hormone and prostaglandin E2-stimulated bone resorption in mouse calvaria without affecting cyclic AMP formation.
    Lerner U; Fredholm BB; Hänström L
    J Oral Pathol; 1985 Sep; 14(8):644-53. PubMed ID: 2995625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of diphenylhydantoin upon enzyme release in relation to collagen degradation in cat palatal mucosa during organ culture.
    Hänström L; Lerner U; Gustafson GT
    Med Biol; 1979 Jun; 57(3):171-6. PubMed ID: 502611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between bone resorption and lysosomal enzyme release as demonstrated by the effect of 1 alpha-hydroxy-vitamin D-3 in an organ culture system.
    Lerner U
    Biochim Biophys Acta; 1980 Oct; 632(2):204-13. PubMed ID: 7417523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A revised role for cyclic AMP in prostaglandin-induced bone resorption.
    Lerner U; Gustafson GT
    Med Biol; 1980 Feb; 58(1):18-24. PubMed ID: 6247586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin inhibits bone resorption and lysosomal enzyme release from bone in organ culture.
    Lerner U
    Scand J Rheumatol; 1980; 9(3):149-56. PubMed ID: 7455622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation and bone metabolism: some characteristics of the bone resorptive effect of thrombin in mouse calvarial bones in vitro.
    Lerner UH; Gustafson GT
    Biochim Biophys Acta; 1988 Mar; 964(3):309-18. PubMed ID: 3126818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
    Lerner UH
    J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bisphosphonates HEBP and AHPrBP but not AHBP inhibit mineral mobilization and lysosomal enzyme release from mouse calvarial bones in tissue culture.
    Lerner U; Larsson A
    Experientia; 1984 Sep; 40(9):965-7. PubMed ID: 6468624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.
    Lerner UH; Fredholm BB; Ransjö M
    Biochem J; 1986 Dec; 240(2):529-39. PubMed ID: 3028378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dibutyryl cyclic AMP and PGE2 on lysosomal enzyme release and lactate production in relation to bone resorption in vitro.
    Lerner U
    Acta Physiol Scand; 1980 Oct; 110(2):123-30. PubMed ID: 6259883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro.
    Lerner U; Ransjö M; Fredholm BB
    Biochem Pharmacol; 1986 Dec; 35(23):4177-89. PubMed ID: 2431692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mithramycin on bone beta-glucuronidase and resorption.
    Kiang DT
    Calcif Tissue Res; 1978 Dec; 26(3):209-13. PubMed ID: 155493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholera toxin on cyclic AMP accumulation and bone resorption in cultured mouse calvaria.
    Ransjö M; Lerner UH
    Biochim Biophys Acta; 1987 Oct; 930(3):378-91. PubMed ID: 2820504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.